2023 Form 5500 filing — Mylan Pharmaceuticals Inc. 401(K) Defined Contribution Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011130500NAL0021908401001) for Mylan Pharmaceuticals Inc. 401(K) Defined Contribution Plan, reported by Mylan Pharmaceuticals Inc. under EIN 55-0455423 and plan number 005. It reports 634 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241011130500NAL0021908401001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Mylan Pharmaceuticals Inc.
- EIN
- 55-0455423
- Plan number
- 005
- Location
- Canonsburg, PA
- Participants
- 634
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $44,288,456
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $44,288,456
- Employer contributions
- $29,232
- Participant contributions
- $25,919
- Total income / additions
- $4,706,428
- Benefits paid
- $8,897,529
- Administrative expenses
- $1,225
- Total expenses
- $8,898,754
- Net increase / (decrease)
- -$4,192,326
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Merrill Lynch, Pierce, Fenner And S | RECORDKEEPER | $1,225 | $0 |